Vigonvita Life Sciences

This study tested the safety and how the body handles a new drug called LV232 in 81 healthy Chinese adults. Participants received either the drug or a placebo, and researchers monitored side effects and drug levels in the blood. The goal was to gather early safety data, not to tr…

This study checks if LV232 capsules are safe and how they move through the body in healthy Chinese adults aged 18-45. About 49 volunteers will take multiple doses or test the effect of food. The goal is to gather safety data, not to treat any disease.

This study looked at how two different versions of an experimental drug are absorbed by the body. It involved 18 healthy Chinese adults who took each version once under fasting conditions. The goal was to compare the drug levels in their blood, not to treat any disease.